Global Ophthalmic Diagnostic Devices Market

Ophthalmic Diagnostic Devices Market Size, Share, Growth Analysis, By Type(Optical Coherence Tomography, Aberrometer & Topography Systems, Fundus Camera, Ophthalmic Ultrasound), By End User(Hospitals, Ophthalmic Clinics, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2725 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 77

Ophthalmic Diagnostic Devices Market Regional Insights

It is expected that North America would hold the largest share of this market, with revenue of USD 907.2 million in 2022. The market for ophthalmic diagnostic devices in the area is anticipated to be driven by high adoption of cutting-edge ophthalmology diagnostic tools, growing awareness of ocular ailments, and rising prevalence of refractive error disorders. Approximately 35.1% of Americans under 50 are myopic, according to a Journal of Current Ophthalmology report. In the upcoming years, it is predicted that the market in this region will grow because of the increased frequency of cataract and myopia.

The market for ophthalmic diagnostic devices is anticipated to be fastest growing in Asia-Pacific. This is explained by the rising elderly population and the high rate of cataract operations in nations like Japan, China, and India. Ophthalmology diagnostic devices market growth in the region is being fueled by a number of important reasons, including increased accessibility of ophthalmic devices and rising awareness of ocular ailments. As an alternative, increased use of technologically advanced ophthalmic equipment is anticipated to drive up market revenue in European nations including the U.K., France, and Germany. A comparably lesser portion of the market was occupied by Latin America, the Middle East, and Africa. The ophthalmic diagnostic equipment market, however, is predicted to rise steadily in Latin America during the next few years.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Ophthalmic Diagnostic Devices Market size was valued at USD 2.56 billion in 2022 and is poised to grow from USD 2.71 billion in 2023 to USD 4.40 billion by 2031, at a CAGR of 6.2% during the forecast period (2024-2031)

The competitive landscape of the ophthalmic diagnostic devices market is characterized by the presence of several key players who offer a wide range of technologically advanced products. These companies strive to develop innovative devices that provide accurate and efficient diagnosis, enabling better patient care. 'Carl Zeiss Meditec AG', 'Topcon Corporation', 'Nidek Co., Ltd.', 'Haag-Streit AG', 'Alcon, Inc.', 'Essilor International S.A.', 'Heidelberg Engineering GmbH', 'Novartis AG', 'Bausch + Lomb Incorporated', 'Johnson & Johnson Vision', 'CooperVision, Inc.', 'Canon Inc.', 'Allergan plc', 'Ziemer Group Holding AG', 'Optovue, Inc.', 'Lumenis Ltd.', 'Leica Microsystems GmbH', 'Hoya Corporation', 'Santen Pharmaceutical Co., Ltd.', 'Oculus Optikgeräte GmbH', 'STAAR Surgical Company', 'Reichert Technologies'

The global healthcare expenditure has been steadily increasing, driven by economic growth, expanding health insurance coverage, and government initiatives to improve healthcare infrastructure. This rise in healthcare spending has positively impacted the ophthalmic diagnostic devices market as healthcare facilities and professionals invest in advanced diagnostic equipment to deliver high-quality eye care services.

Ophthalmic diagnostic devices generate a vast amount of data, including imaging data, patient records, and treatment outcomes. The integration of big data analytics allows for efficient storage, analysis, and interpretation of this data, enabling better decision-making, personalized treatment plans, and the development of predictive models for disease progression.

It is expected that North America would hold the largest share of this market, with revenue of USD 907.2 million in 2022. The market for ophthalmic diagnostic devices in the area is anticipated to be driven by high adoption of cutting-edge ophthalmology diagnostic tools, growing awareness of ocular ailments, and rising prevalence of refractive error disorders. Approximately 35.1% of Americans under 50 are myopic, according to a Journal of Current Ophthalmology report. In the upcoming years, it is predicted that the market in this region will grow because of the increased frequency of cataract and myopia.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Ophthalmic Diagnostic Devices Market

Report ID: SQMIG35A2725

$5,300
BUY NOW GET FREE SAMPLE